Rocket Pharmaceuticals Inc

NASDAQ:RCKT   4:00:00 PM EDT
2.45
-0.08 (-3.16%)
7:59:18 PM EDT: $2.43 -0.02 (-0.79%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Rocket Pharmaceuticals Inc Stock, NASDAQ:RCKT

9 Cedarbrook Drive, 350 5th Avenue, Cranbury, New Jersey 08512
United States of America
Phone: +1.609.659.8001
Number of Employees: 299

Description

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.